Search Browse Earnings

Oric Pharmaceuticals, Inc. — SlamSEC

Oric Pharmaceuticals, Inc.

Nasdaq:ORIC

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$141.8M

FY 2025

Net Income

-$127.8M

FY 2025

EPS (Diluted)

-$1.83

FY 2025

Stock Price

$11.90

+1.2%

2026-03-13

52W Range

$3.90 – $14.93

P/E Ratio

-6.5x

Market Cap

$1.2B

Cash

$59.4M

FY 2025

Total Debt

$10.5M

FY 2021

Net Cash

$48.9M

FY 2021

Enterprise Value

$1.1B

Debt / EBITDA

0.3x

FY 2025

EV / EBITDA

-8.1x

Employees

—